UCB US is a global biopharmaceutical company dedicated to improving the lives of individuals with severe diseases and unmet needs. With headquarters in Brussels, Belgium and a strong presence in the United States, UCB prioritizes patient value by placing people at the center of everything they do. From discovery to development to delivery, the company is committed to transforming and redesigning its processes around the patient experience.

UCB offers impactful solutions for a range of disease areas and focuses on delivering innovative therapies. From their U. S.

They have additional U. S. By driving innovation, fulfilling their commitment, and striving to provide a meaningful experience for patients, UCB is at the forefront of advancements in healthcare.

With a focus on patient well-being and addressing their unique needs, UCB is shaping the future of biopharmaceuticals